UNDERSTANDING SUPRATHRESHOLD HEARING DEFICITS

了解阈上听力缺陷

基本信息

  • 批准号:
    9465797
  • 负责人:
  • 金额:
    $ 42.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-21 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Sensorineural hearing loss (SNHL) can occur as a result of dysfunction of outer hair cells, inner hair cells, auditory-nerve fibers or synapses. However, standard clinical techniques are limited in their ability to differentiate these dysfunctions because they focus on threshold elevation and thus provide insufficient information about suprathreshold auditory dysfunction, which has greater ecological validity than threshold elevation. SNHL that does not elevate thresholds, and therefore would be missed by standard clinical techniques, is sometimes referred to as “hidden hearing loss” (HHL). Recent animal studies suggest that noise-induced synaptopathy may underlie HHL and may be the cause of suprathreshold hearing deficits, such as difficulty understanding speech in noise. However, there is limited research to support the diagnosis of HHL in humans beyond reports that some individuals have suprathreshold hearing deficits that cannot be predicted from their audiograms. Understanding HHL in humans will require the use of measurements of auditory function that are specific to the location of the dysfunction in the auditory pathway, including the specific group of auditory-nerve fibers (low vs. high spontaneous-rate fibers) underlying the dysfunction. The long-term goals of this research program are to improve our understanding of suprathreshold hearing deficits and to develop intervention strategies that ameliorate these deficits. The immediate goal of this proposal is to establish a theoretical framework for the development of diagnostic methods for HHL in humans. Unfortunately, a “gold standard” does not exist because synaptopathy cannot be directly observed in humans. Consequently, our approach is to develop a statistical model of HHL that describes the relationship and interdependence between specific behavioral and physiological measures of auditory function that are thought to be indicative of HHL and measures that reflect the functional integrity of sites along the auditory pathway. The goal will be achieved by pursuing three aims: (1) Develop a statistical model of HHL for individuals with normal hearing, (2) Develop a statistical model of HHL for individuals with clinical hearing loss caused by noise exposure, and (3) Validate a predictive model of HHL and demonstrate its relation to speech understanding in noise. We will establish a functional definition of HHL as a component of the variability in measures impacted by HHL that is not due to audiometric threshold. We will then create a statistical model that relates this estimate of HHL to measures that reflect sites of dysfunction along the auditory pathway. Through the aims, we will test the hypothesis that HHL accounts for some of the variability in suprathreshold measures of auditory function. The proposed research will lead to evidence-based models of suprathreshold auditory dysfunction that are capable of predicting hearing deficits, provide further insights into suprathreshold auditory deficits and improve our understanding of potential mechanisms underlying hearing and listening difficulties. The ability to diagnose HHL in the clinic will usher in new methods for clinical evaluation and may lead to better remediation techniques of hearing loss.
PROJECT SUMMARY/ABSTRACT Sensorineural hearing loss (SNHL) can occur as a result of dysfunction of outer hair cells, inner hair cells, auditory-nerve fibers or synapses. However, standard clinical techniques are limited in their ability to differentiate these dysfunctions because they focus on threshold elevation and thus provide insufficient information about suprathreshold auditory dysfunction, which has greater ecological validity than threshold elevation. SNHL that does not elevate thresholds, and therefore would be missed by standard clinical techniques, is sometimes referred to as “hidden hearing loss” (HHL). Recent animal studies suggest that noise-induced synaptopathy may underlie HHL and may be the cause of suprathreshold hearing deficits, such as difficulty understanding speech in noise. However, there is limited research to support the diagnosis of HHL in humans beyond reports that some individuals have suprathreshold hearing deficits that cannot be predicted from their audiograms. Understanding HHL in humans will require the use of measurements of auditory function that are specific to the location of the dysfunction in the auditory pathway, including the specific group of auditory-nerve fibers (low vs. high spontaneous-rate fibers) underlying the dysfunction. The long-term goals of this research program are to improve our understanding of suprathreshold hearing deficits and to develop intervention strategies that ameliorate these deficits. The immediate goal of this proposal is to establish a theoretical framework for the development of diagnostic methods for HHL in humans. Unfortunately, a “gold standard” does not exist because synaptopathy cannot be directly observed in humans. Consequently, our approach is to develop a statistical model of HHL that describes the relationship and interdependence between specific behavioral and physiological measures of auditory function that are thought to be indicative of HHL and measures that reflect the functional integrity of sites along the auditory pathway. The goal will be achieved by pursuing three aims: (1) Develop a statistical model of HHL for individuals with normal hearing, (2) Develop a statistical model of HHL for individuals with clinical hearing loss caused by noise exposure, and (3) Validate a predictive model of HHL and demonstrate its relation to speech understanding in noise. We will establish a functional definition of HHL as a component of the variability in measures impacted by HHL that is not due to audiometric threshold. We will then create a statistical model that relates this estimate of HHL to measures that reflect sites of dysfunction along the auditory pathway. Through the aims, we will test the hypothesis that HHL accounts for some of the variability in suprathreshold measures of auditory function. The proposed research will lead to evidence-based models of suprathreshold auditory dysfunction that are capable of predicting hearing deficits, provide further insights into suprathreshold auditory deficits and improve our understanding of potential mechanisms underlying hearing and listening difficulties. The ability to diagnose HHL in the clinic will usher in new methods for clinical evaluation and may lead to better remediation techniques of hearing loss.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel M. Rasetshwane其他文献

Daniel M. Rasetshwane的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel M. Rasetshwane', 18)}}的其他基金

UNDERSTANDING SUPRATHRESHOLD HEARING DEFICITS
了解阈上听力缺陷
  • 批准号:
    9759914
  • 财政年份:
    2017
  • 资助金额:
    $ 42.51万
  • 项目类别:
Restoring Cochlear Signal Processing
恢复耳蜗信号处理
  • 批准号:
    8748339
  • 财政年份:
    2014
  • 资助金额:
    $ 42.51万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 42.51万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.51万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 42.51万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.51万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 42.51万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.51万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 42.51万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 42.51万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 42.51万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.51万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了